Software Engineer Intern - Fall 2026

Department: AI

Location: San Mateo, CA, New York, NY

Employment Type: Intern

Genesis Molecular AI is building a world-class software team to solve problems in drug discovery through machine learning, biophysical simulation, and computational chemistry. We are looking for engineers excited to help develop new medicines and play a critical role in building out our software platform.

You will

• Build and expand on tools for visualizing molecules and proteins, analyzing machine learning models, and managing complex chemical workflows

• Work closely with machine learning engineers and medicinal chemists to develop and productionize new computational methods for molecular property prediction

• Help scale our core infrastructure to handle billions of datapoints and thousands of parallel deep learning and molecular dynamics jobs

You are

• A strong software engineer who will write code quickly and uphold our code quality standards

• A deep thinker who reasons from first principles over pattern matching

• Interested in learning about biochemistry and the drug development process

What we offer

• The opportunity to work on high impact tools and products that are immediately deployed to accelerate the discovery of new medicines

• Strong technical coworkers in AI, software, and chemistry, who all have a powerful mix of intellectual curiosity and humility. The team reads and discusses 1-2 machine learning or chemistry papers every week to stay on top of the field and inspire new ideas

Application & Hiring Timeline

• Application Deadline: April 24, 2026

• Resume Review: Beginning May 4, 2026

• Interviews Kick-Off: May 11, 2026

About Genesis Molecular AI

Genesis Molecular AI is pioneering foundation models for molecular AI to unlock a new era of drug design and development. The company’s generative and predictive AI platform, GEMS (Genesis Exploration of Molecular Space), integrates AI and physics into industry-leading models to generate and optimize drug molecules, including the breakthrough generative diffusion model Pearl for structure prediction. Genesis has raised over $300 million from leading AI, tech and life science-focused investors, signed multiple AI-focused research collaborations with major pharma partners, and is deploying GEMS to advance an internal therapeutics pipeline for a variety of high-impact targets.

Genesis is headquartered in San Mateo, CA, with a fully integrated laboratory in San Diego. We are proud to be an inclusive workplace and an Equal Opportunity Employer.